Zhejiang Shouxiangu Pharm Co (603896) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Zhejiang Shouxiangu Pharm Co (603896) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.94 Million ≈ $3.06 Million USD) by net assets (CN¥2.31 Billion ≈ $338.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Shouxiangu Pharm Co - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Zhejiang Shouxiangu Pharm Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Shouxiangu Pharm Co debt and liabilities for a breakdown of total debt and financial obligations.

Zhejiang Shouxiangu Pharm Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shouxiangu Pharm Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nanning Department Store Co Ltd SHG:600712	0.000x
Ranpak Holdings Corp NYSE:PACK	0.016x
ForFarmers NV AS:FFARM	0.158x
Shenzhen Minkave Technology Co Ltd SHE:300506	1.152x
IS Dongseo KO:010780	0.003x
Sichuan Golden Summit Group Joint Stock Co Ltd SHG:600678	0.058x
Sichuan Troy Information Technology Co Ltd SHE:300366	-0.022x
DHG Pharmaceutical JSC VN:DHG	0.107x

Annual Cash Flow Conversion Efficiency for Zhejiang Shouxiangu Pharm Co (2012–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shouxiangu Pharm Co from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Shouxiangu Pharm Co market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.29 Billion ≈ $335.69 Million	CN¥213.44 Million ≈ $31.23 Million	0.093x	-35.88%
2023-12-31	CN¥2.17 Billion ≈ $317.73 Million	CN¥315.06 Million ≈ $46.10 Million	0.145x	-18.98%
2022-12-31	CN¥1.91 Billion ≈ $278.84 Million	CN¥341.28 Million ≈ $49.94 Million	0.179x	-2.21%
2021-12-31	CN¥1.62 Billion ≈ $237.06 Million	CN¥296.70 Million ≈ $43.42 Million	0.183x	-5.25%
2020-12-31	CN¥1.33 Billion ≈ $194.08 Million	CN¥256.36 Million ≈ $37.51 Million	0.193x	+9.00%
2019-12-31	CN¥1.17 Billion ≈ $171.57 Million	CN¥207.92 Million ≈ $30.42 Million	0.177x	+1.82%
2018-12-31	CN¥984.74 Million ≈ $144.10 Million	CN¥171.51 Million ≈ $25.10 Million	0.174x	+36.71%
2017-12-31	CN¥869.75 Million ≈ $127.27 Million	CN¥110.80 Million ≈ $16.21 Million	0.127x	-41.72%
2016-12-31	CN¥436.93 Million ≈ $63.94 Million	CN¥95.52 Million ≈ $13.98 Million	0.219x	-5.25%
2015-12-31	CN¥368.53 Million ≈ $53.93 Million	CN¥85.03 Million ≈ $12.44 Million	0.231x	-28.12%
2014-12-31	CN¥320.56 Million ≈ $46.91 Million	CN¥102.90 Million ≈ $15.06 Million	0.321x	+45.99%
2013-12-31	CN¥299.50 Million ≈ $43.83 Million	CN¥65.85 Million ≈ $9.64 Million	0.220x	-32.93%
2012-12-31	CN¥138.37 Million ≈ $20.25 Million	CN¥45.36 Million ≈ $6.64 Million	0.328x	--

About Zhejiang Shouxiangu Pharm Co

SHG:603896 China Biotechnology

Market Cap

$503.60 Million

CN¥3.44 Billion CNY

Market Cap Rank

#12531 Global

#3900 in China

Share Price

CN¥17.36

Change (1 day)

-0.69%

52-Week Range

CN¥17.36 - CN¥23.36

All Time High

CN¥56.07